Trials / Completed
CompletedNCT01201161
Ranibizumab for Diabetic Traction Retinal Detachment
The Effect of Intravitreous Ranibizumab on Intra-Operative Bleeding During Pars Plana Vitrectomy for Diabetic Traction Retinal Detachment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the effect of ranibizumab in reducing intraoperative vitreous haemorrhage during pars plana vitrectomy, thus facilitating surgery and improving its anatomical and functional results in patients with advanced proliferative diabetic retinopathy and traction retinal detachment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranibizumab | Intravitreal injection of ranibizumab 0.05 ml (0.5 mg) one week before pars plana vitrectomy |
| OTHER | Sham injection | Simulation of intravitreal injection one week before pars plana vitrectomy |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2010-09-14
- Last updated
- 2010-09-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01201161. Inclusion in this directory is not an endorsement.